Actively Recruiting
Prospective Study of Sinonasal and Skull-base Tumours Management
Led by University Medical Centre Ljubljana · Updated on 2026-04-29
120
Participants Needed
1
Research Sites
312 weeks
Total Duration
On this page
Sponsors
U
University Medical Centre Ljubljana
Lead Sponsor
U
University of Ljubljana, Faculty of Medicine
Collaborating Sponsor
AI-Summary
What this Trial Is About
This observational prospective clinical study aims to describe the epidemiology, management and outcome of patients with sinonasal and skull-base pathology (tumours and diseases with malignant clinical characteristics) in a tertiary otorhinolaryngology referral centre. The main questions it aims to answer are: * what is the caseload of patients with the included pathology in our centre * what are the results of management of these cases * what are the epidemiological characteristics of included patients * what is the quality of life of included patients.
CONDITIONS
Official Title
Prospective Study of Sinonasal and Skull-base Tumours Management
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of sinonasal and/or skull-base cancer
- Sinonasal disease extending through the skull base
- Provided written informed consent to participate
You will not qualify if you...
- Disease located in the lateral skull base primarily originating in the temporal bone without central skull-base involvement
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Medical Centre Ljubljana
Ljubljana, Ljubljana, Slovenia, 1000
Actively Recruiting
Research Team
D
Domen Vozel, MD, PhD
CONTACT
J
Jure Urbančič, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here